J 2019

Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes

JANKŮ, Petr, Marian KACEROVSKY, Barbora ZEDNIKOVA, Ctirad ANDRYS, Martina KOLACKOVA et. al.

Basic information

Original name

Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes

Authors

JANKŮ, Petr (203 Czech Republic, belonging to the institution), Marian KACEROVSKY (203 Czech Republic, guarantor), Barbora ZEDNIKOVA (203 Czech Republic), Ctirad ANDRYS (203 Czech Republic), Martina KOLACKOVA (203 Czech Republic), Marcela DRAHOSOVA (203 Czech Republic), Lenka PLISKOVA (203 Czech Republic), Helena ZEMLICKOVA (203 Czech Republic), Romana GERYCHOVÁ (203 Czech Republic, belonging to the institution), Ondrej SIMETKA (203 Czech Republic), Petr MATLAK (203 Czech Republic), Bo JACOBSSON (752 Sweden) and Ivana MUSILOVA (203 Czech Republic)

Edition

Fetal Diagnosis and Therapy, Basel, Karger, 2019, 1015-3837

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30214 Obstetrics and gynaecology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.095

RIV identification code

RIV/00216224:14110/19:00112965

Organization unit

Faculty of Medicine

UT WoS

000507387300007

Keywords in English

Inflammation; Microorganism; Pattern recognition receptor; Preterm birth

Tags

Tags

International impact, Reviewed
Změněno: 11/5/2020 13:30, Mgr. Tereza Miškechová

Abstract

V originále

Problem: To determine the changes of pentraxin 3 (PTX3) level in noninvasively obtained cervical fluid samples from women with preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI), and intra-amniotic infection (the presence of both MIAC and IAI). Methods of Study: A total of 160 women with PPROM were included. Cervical fluid samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Cervical fluid PTX3 levels were assessed using enzyme-linked immunosorbent assay. Results: PTX3 was found in all the cervical fluid samples and its levels were higher in women with MIAC, IAI, and intra-amniotic infection than in women without these conditions. When the women were categorized into four subgroups based on the presence of MIAC and/or IAI, women with intra-amniotic infection had higher cervical fluid PTX3 levels than those with sterile IAI (IAI alone), colonization (MIAC alone), or no MIAC or IAI. A cervical fluid PTX3 level of 11 ng/mL was the best value for identifying the presence of intra-amniotic infection in women with PPROM. Conclusions: PTX3 is a constituent of cervical fluid of women with PPROM. Cervical fluid PTX3 level reflects the situation in the intra-amniotic compartments of women with PPROM. Cervical fluid PTX3 is a potential marker for the noninvasive identification of intra-amniotic infection in PPROM.